Wayne Winegarden

Biosimilars

The Biosimilar Promise

Despite Achievements, Barriers That Discourage Biosimilar Use Remain

Despite Achievements, Barriers That Discourage Biosimilar Use Remain By Wayne Winegarden  | December 2, 2024 READ PDF Executive Summary The Inflation Reduction Act’s price controls discourage biosimilar development. Payment system inefficiencies, such as the buy-and-bill payment system and rebate walls, disincentivize the use of lower cost biosimilars. Despite the savings ...
Biosimilars

The Biosimilar Promise

Low-Cost Biosimilars Are Saving Billions, Potential Savings Are Even Greater

Low-Cost Biosimilars Are Saving Billions, Potential Savings Are Even Greater By Wayne Winegarden  | October 28, 2024 READ PDF Executive Summary   Since 2019, biosimilars have obtained a majority share of most markets where they compete. The combination of lower prices (both biosimilar and originator) and rising market share could ...
Commentary

Learn more about how price controls are driving physician shortages

Price Controls Are Harming Doctors

Whether its pharmaceuticals or health insurance, Vice President Kamala Harris appears to have only one healthcare policy – impose price controls. The untenable financial position of many doctors and private doctor practices due to tightening Medicare reimbursement rates exemplifies the folly of her preferred approach. As I document in a recent ...
Blog

Learn how drug price controls hurt patients, innovation

Senator Sanders’ Price Controls Will Harm Patients

In a patently politicized press release, Senator Bernie Sanders (I-VT) who is  Chairman of the Senate Health, Education, Labor, and Pensions (HELP) Committee, claims that the U.S. price of Ozempic is too high. As evidence, he cites generic companies that claim they can sell Ozempic for less than $100 a ...
Commentary

Learn why drug price controls don't work

The Expected Consequences Of Price Controls

The intended consequence of the policy is to reduce overall spending on drugs, but all regulations have unintended consequences, too. While these consequences may be unintended, they need not be unexpected. In the case of the IRA, these unintended impacts now threaten to undermine the entire purpose of the policy. ...
Blog

Read the latest on California's outmigration problem

Don’t Forget About Migration’s Long-term Implications

This exodus reflects the migrant’s view that California no longer offers a competitive lifestyle, and the state provides residents with inadequate economic opportunities. But the exodus from the state is not simply a statement on the Golden State’s current maladies. When people migrate, they take their income and economic activity ...
Business & Economics

NEW BRIEF: CalPERS’ Political Agenda Puts Taxpayers and Retirees at Risk with Low Returns, Higher Unfunded Liabilities

SACRAMENTO – CalPERS – which adheres to a politicized Environmental, Social, and Governance (ESG) agenda – is generating lower returns in its investment strategies compared to a more typical investment strategy, finds a new brief released today by the Pacific Research Institute, a non-partisan California-based free market think tank. CalPERS ...
Blog

Spending Watch

California’s Expensive but Ineffective Income Support Spending

California’s Expensive but Ineffective Income Support Spending Wayne Winegarden August 2024 Including federal, state, and local funds, California’s per capita spending on income support programs is 81 percent higher than the average expenditures for all other states – per capita spending of $3,869 compared to $2,141. These expenditures include “cash ...
Commentary

Learn about the damage from lawsuit abuse

Tort Abuses Threat To Innovation And Product Availability

Not only is continued invention necessary for expanding our prosperity, but it is also key for mitigating problems such as global climate change or finding new technologies and treatments for troubling health conditions. Take the state and municipal lawsuits being filed against energy companies as an example. When announcing his ...
Blog

CAPITAL IDEAS: Environmental, Social and Governance (ESG) Undermines the Social Responsibility of Businesses and Investment Managers

The concepts behind Environmental, Social, and Governance (ESG) investing and management are the latest theory trying to address a long-standing question: What is the appropriate social function of a business? This question predates Milton Friedman’s 1970 New York Times piece “The Social Responsibility of Business Is to Increase Its Profits,” ...
Biosimilars

The Biosimilar Promise

Despite Achievements, Barriers That Discourage Biosimilar Use Remain

Despite Achievements, Barriers That Discourage Biosimilar Use Remain By Wayne Winegarden  | December 2, 2024 READ PDF Executive Summary The Inflation Reduction Act’s price controls discourage biosimilar development. Payment system inefficiencies, such as the buy-and-bill payment system and rebate walls, disincentivize the use of lower cost biosimilars. Despite the savings ...
Biosimilars

The Biosimilar Promise

Low-Cost Biosimilars Are Saving Billions, Potential Savings Are Even Greater

Low-Cost Biosimilars Are Saving Billions, Potential Savings Are Even Greater By Wayne Winegarden  | October 28, 2024 READ PDF Executive Summary   Since 2019, biosimilars have obtained a majority share of most markets where they compete. The combination of lower prices (both biosimilar and originator) and rising market share could ...
Commentary

Learn more about how price controls are driving physician shortages

Price Controls Are Harming Doctors

Whether its pharmaceuticals or health insurance, Vice President Kamala Harris appears to have only one healthcare policy – impose price controls. The untenable financial position of many doctors and private doctor practices due to tightening Medicare reimbursement rates exemplifies the folly of her preferred approach. As I document in a recent ...
Blog

Learn how drug price controls hurt patients, innovation

Senator Sanders’ Price Controls Will Harm Patients

In a patently politicized press release, Senator Bernie Sanders (I-VT) who is  Chairman of the Senate Health, Education, Labor, and Pensions (HELP) Committee, claims that the U.S. price of Ozempic is too high. As evidence, he cites generic companies that claim they can sell Ozempic for less than $100 a ...
Commentary

Learn why drug price controls don't work

The Expected Consequences Of Price Controls

The intended consequence of the policy is to reduce overall spending on drugs, but all regulations have unintended consequences, too. While these consequences may be unintended, they need not be unexpected. In the case of the IRA, these unintended impacts now threaten to undermine the entire purpose of the policy. ...
Blog

Read the latest on California's outmigration problem

Don’t Forget About Migration’s Long-term Implications

This exodus reflects the migrant’s view that California no longer offers a competitive lifestyle, and the state provides residents with inadequate economic opportunities. But the exodus from the state is not simply a statement on the Golden State’s current maladies. When people migrate, they take their income and economic activity ...
Business & Economics

NEW BRIEF: CalPERS’ Political Agenda Puts Taxpayers and Retirees at Risk with Low Returns, Higher Unfunded Liabilities

SACRAMENTO – CalPERS – which adheres to a politicized Environmental, Social, and Governance (ESG) agenda – is generating lower returns in its investment strategies compared to a more typical investment strategy, finds a new brief released today by the Pacific Research Institute, a non-partisan California-based free market think tank. CalPERS ...
Blog

Spending Watch

California’s Expensive but Ineffective Income Support Spending

California’s Expensive but Ineffective Income Support Spending Wayne Winegarden August 2024 Including federal, state, and local funds, California’s per capita spending on income support programs is 81 percent higher than the average expenditures for all other states – per capita spending of $3,869 compared to $2,141. These expenditures include “cash ...
Commentary

Learn about the damage from lawsuit abuse

Tort Abuses Threat To Innovation And Product Availability

Not only is continued invention necessary for expanding our prosperity, but it is also key for mitigating problems such as global climate change or finding new technologies and treatments for troubling health conditions. Take the state and municipal lawsuits being filed against energy companies as an example. When announcing his ...
Blog

CAPITAL IDEAS: Environmental, Social and Governance (ESG) Undermines the Social Responsibility of Businesses and Investment Managers

The concepts behind Environmental, Social, and Governance (ESG) investing and management are the latest theory trying to address a long-standing question: What is the appropriate social function of a business? This question predates Milton Friedman’s 1970 New York Times piece “The Social Responsibility of Business Is to Increase Its Profits,” ...
Scroll to Top